We’re joined by Professor Archie Clements who is Pro Vice-Chancellor of Health Sciences at Curtin University, Australia. He shares his views on the Malaria World Congress that took place in Melbourne earlier this year, and on the FDA’s approval of Tafenoquine.
Since the story broke of Harvey Weinstein’s sexual misconduct, there’s been an increase in feminism, with the MeToo movement demanding equality. Elena and Joanne have created a website called ‘Women in Malaria’, it acts as a platform for women working in malaria research.
Dr Michelle Wykes runs the Molecular Immunology unit at QIMR Berghofer Medical Research Institute and has been focusing on trying to improve the immune system’s response to a malaria infection. We discuss her recent work in malaria research which has been hailed as a breakthrough.
We speak with John Dowe of the International Mefloquine Veterans Alliance. The Alliance is a network of individuals affected by the health impacts of Mefloquine and Tafenoquine. Their aim is to support those who are dealing with the complex health implications of the drug’s toxicity.
As part of our ongoing podcast series investigating the antimalarial drugs Tafenoquine and Mefloquine, I speak with Professor Jane Quinn, an army widow. She shares her personal experience with Mefloquine and tells me what kind of side effects an individual may experience from taking the drug.
Tafenoquine is safe and effective, according to the Australian researcher, Professor James McCarthy. He tells us how Tafenoquine and Mefloquine are very different in how they interact with the body.
Meet the man that opposes the use of Tafenoquine. Dr Remington Nevin runs an organisation lobbying against the use of Tafenoquine and other Quinolines. In this interview, he tells us the real reason for why GSK and 60 Degrees are developing the drug, which the U.S. army abandoned (it’s to do with money).
In this episode of Five Minutes, we speak with Thomas Stewart, a Programme Manager from The Mentor Initiative. He tells us about his work in malaria control and why it’s now more important than ever to eliminate malaria.
We speak with Professor Jake Baum of Imperial College London. He has been thrust in the spotlight for what the ‘Independent’ is calling a ‘major malaria breakthrough’. His team is working on trying to find a set of compounds that stop mosquitoes from contracting malaria when they bite an infected person.
The PMI VectorLink Project is equipping countries to plan and implement sustainable Indoor Residual Spraying programs and other life-saving malaria control interventions. I wanted to know what’s changed in the malaria field and what they are currently doing to end malaria.